Emerging Trends in Immunodermatology and Autoimmune Skin Disorders
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 25 October 2026 | Viewed by 1533
Special Issue Editors
Interests: cutaneous endotyping; pharmacovigilance and inflammatory dermatoses; cancerization field
Special Issues, Collections and Topics in MDPI journals
Interests: systemic lupus erythematosus; systemic sclerosis; Raynaud’s phenomenon
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of immunodermatology has undergone significant transformation over the past years, driven by growing insights into the immune system’s role in skin physiology and pathology. Autoimmune skin disorders are currently at the forefront of dermatological research thanks to advances in immunology, molecular biology, and bioinformatics. Conditions such as vitiligo, systemic sclerosis, dermatomyositis, lupus erythematosus, pemphigoid, and pemphigus have revealed complex immune-mediated mechanisms that challenge our understanding of skin disease and present new treatment perspectives.
Background and History
Historically, autoimmune skin diseases were approached through symptomatic management. Over the last two decades, the identification of key cytokines, T-cell subsets, autoantigens, and genetic risk factors has redefined our knowledge and led to the development of new treatment strategies. The advent of biologic therapies targeting specific immune pathways, such as TNF-α, IL-17, IL-23, and JAK/STAT signaling, has dramatically improved patient outcomes, and ongoing research continues to uncover novel immunological targets.
Aim and Scope of the Special Issue
This Special Issue aims to highlight the most recent advances and future directions in immunodermatology, with a focus on autoimmune skin disorders in order to present novel findings, discuss emerging therapeutic approaches, and explore the immunopathological mechanisms underlying these conditions. By bringing together interdisciplinary perspectives, we aim to foster innovation and crosstalk between basic research, clinical practice, and translational science.
Cutting-Edge Research Areas
We are particularly interested in manuscripts that explore the following areas:
- The immunogenetics and molecular pathways involved in autoimmune skin diseases;
- Novel biomarkers for early diagnosis, prognosis, and treatment response;
- Innovations in targeted therapies and immunomodulatory approaches;
- The role of the skin microbiome and environmental triggers in disease pathogenesis;
- Systems biology, multi-omics, and artificial intelligence applications in immunodermatology;
- Insights from clinical trials and real-world evidence in the management of these disorders;
- Cutaneous autoimmune disorders and their clinical and systemic implications;
- The application of imaging techniques in the diagnostic process of autoimmune skin disorders.
Authors are welcome to submit original articles, reports on novel treatment strategies and advances in decision-making, clinical outcome studies, comparative studies, narrative reviews, scoping reviews and systematic reviews and meta-analyses.
This Special Issue will serve as a timely compendium for academics, clinicians, and industry professionals seeking to stay abreast of the rapidly evolving landscape of autoimmune skin disorders and immunodermatology.
We look forward to your contributions and to advancing the frontiers of this dynamic and impactful field.
Dr. Giovanni Damiani
Guest Editor
Dr. Magdalena Spałkowska
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune skin disorders
- cutaneous lupus erythematosus
- systemic lupus erythematosus
- autoantibodies
- systemic sclerosis
- dermatomyositis
- vitiligo
- pemphigus
- pemphigoid
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
